Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Fumisato Maesaka"'
Publikováno v:
IJU Case Reports, Vol 7, Iss 6, Pp 480-483 (2024)
Introduction Radiotherapy for widespread bone metastasis results in severe hematological toxicity. Case presentation A 71‐year‐old male was diagnosed with metastatic hormone‐sensitive prostate cancer (cT4N1M1b) and treated with apalutamide and
Externí odkaz:
https://doaj.org/article/5a33d9003f3d432d9feac9a1e4076469
Autor:
Takuya Owari, Makito Miyake, Yasushi Nakai, Nobumichi Tanaka, Yoshitaka Itami, Shuya Hirao, Hitoshi Momose, Yoshinori Nakagawa, Kouta Iida, Fumisato Maesaka, Takuto Shimizu, Yusuke Iemura, Yoshihiro Matsumoto, Masaomi Kuwada, Takeshi Otani, Kenji Otsuka, Eijiro Okajima, Yukinari Hosokawa, Ryosuke Okamura, Kiyohide Fujimoto
Publikováno v:
Journal of Bone Oncology, Vol 26, Iss , Pp 100344- (2021)
Objective: We previously developed genitourinary (GU) cancer-specific scoring system for prediction of survival in patients with bone metastasis (the Bone-Fujimoto-Owari-Miyake [B-FOM] scoring model) based on five prognostic factors: the type of prim
Externí odkaz:
https://doaj.org/article/c74aa3e244c64d51bd2395cd81432b31
Autor:
Shunta Hori, Mitsuru Tomizawa, Fumisato Maesaka, Takuya Owari, Yosuke Morizawa, Yasushi Nakai, Makito Miyake, Tatsuo Yoneda, Nobumichi Tanaka, Katsunori Yoshida, Kiyohide Fujimoto
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-5 (2018)
Abstract Background Page kidney phenomenon is caused by strong renal parenchymal compression and leads to renal hypoperfusion and microvascular ischemia, resulting in renal dysfunction and hypertension. Although the development of Page kidney phenome
Externí odkaz:
https://doaj.org/article/29c470b4900a45ca97bfb1331525d9dc
Autor:
Makito Miyake, Fumisato Maesaka, Nagaaki Marugami, Tatsuki Miyamoto, Yasushi Nakai, Sayuri Ohnishi, Daisuke Gotoh, Takuya Owari, Shunta Hori, Yosuke Morizawa, Yoshitaka Itami, Takeshi Inoue, Satoshi Anai, Kazumasa Torimoto, Tomomi Fujii, Keiji Shimada, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Diagnostics, Vol 9, Iss 3, p 112 (2019)
The detection of carcinoma in situ (CIS) is essential for the management of high-risk non-muscle invasive bladder cancers. Here, we focused on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) combined with photodynamic diagnosis (PDD) f
Externí odkaz:
https://doaj.org/article/8c4c78795409479a99f0c5405b6e761d
Autor:
Nobutaka Nishimura, Makito Miyake, Takuto Shimizu, Toshihiko Matsubara, Tatsuki Miyamoto, Keichi Sakamoto, Atsushi Yamada, Yoshihiro Matsumoto, Motokiyo Yoshikawa, Kazuki Ichikawa, Chihiro Omori, Fumisato Maesaka, Yuki Oda, Keisuke Kiba, Atsushi Tomioka, Yukinari Hosokawa, Masahiro Tanaka, Takeshi Otani, Kiyohide Fujimoto
Publikováno v:
International journal of clinical oncology. 27(11)
First-line pembrolizumab is available for recurrent disease within 12 months after the receipt of platinum-based perioperative chemotherapy. However, the benefit of first-line pembrolizumab is unclear. This study evaluated the oncological outcome of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1155d723e86a0d407efd263e761ddca
https://pubmed.ncbi.nlm.nih.gov/36029377
https://pubmed.ncbi.nlm.nih.gov/36029377
Autor:
Shohei Horii, Shiori Mori, Ruiko Ogata, Shota Nukaga, Ryoichi Nishida, Shingo Kishi, Rika Sasaki, Ayaka Ikemoto, Takuya Owari, Fumisato Maesaka, Kanya Honoki, Makito Miyake, Yasuhito Tanaka, Kiyohide Fujimoto, Rina Fujiwara-Tani, Hiroki Kuniyasu
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 7; Pages: 6189
5-aminolevulinic acid (ALA) is used for tumor-targeting phototherapy because it is converted to protoporphyrin IX (PPIX) upon excitation and induces phototoxicity. However, the effect of ALA on malignant cells under unexcited conditions is unclear. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f390d8c7f9d72909dcb20cff67e1757a
https://doi.org/10.3390/ijms24076189
https://doi.org/10.3390/ijms24076189
Autor:
Fumisato, Maesaka, Masaomi, Kuwada, Shohei, Horii, Shingo, Kishi, Rina, Fujiwara-Tani, Shiori, Mori, Kiyomu, Fujii, Takuya, Mori, Hitoshi, Ohmori, Takuya, Owari, Makito, Miyake, Yasushi, Nakai, Nobumichi, Tanaka, Ujjal Kumar, Bhawal, Yi, Luo, Masuo, Kondoh, Kiyohide, Fujimoto, Hiroki, Kuniyasu
Publikováno v:
International journal of molecular sciences. 23(12)
The tight junction (TJ) protein claudin-4 (CLDN4) is overexpressed in bladder urothelial carcinoma (BUC) and correlates with cancer progression. However, the mechanism of CLDN4 upregulation and promotion of malignant phenotype is not clear. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6f935b829ae660c1dbeae9c8a4d4c750
https://pubmed.ncbi.nlm.nih.gov/35742959
https://pubmed.ncbi.nlm.nih.gov/35742959
Autor:
Takuto Shimizu, Makito Miyake, Nobutaka Nishimura, Kuniaki Inoue, Koyo Fujii, Yusuke Iemura, Kazuki Ichikawa, Chihiro Omori, Mitsuru Tomizawa, Fumisato Maesaka, Yuki Oda, Tatsuki Miyamoto, Keiichi Sakamoto, Keisuke Kiba, Masahiro Tanaka, Nobuo Oyama, Eijiro Okajima, Ken Fujimoto, Shunta Hori, Yosuke Morizawa, Daisuke Gotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Publikováno v:
Cancers; Volume 14; Issue 7; Pages: 1735
To investigate the organ-specific response and clinical outcomes of mixed responses (MRs) to immune checkpoint inhibitors (ICIs) for unresectable or metastatic urothelial carcinoma (ur/mUC), we retrospectively analyzed 136 patients who received pembr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36aa0e8b334f7de58004eac3c6008944
Autor:
Makito Miyake, Chihiro Ohmori, Katsuya Aoki, Nobutaka Nishimura, Shunta Hori, Kazumasa Torimoto, Yasushi Nakai, Yosuke Morizawa, Fumisato Maesaka, Yoshiaki Matsumura, Daisuke Gotoh, Yuki Oda, Kazuki Ichikawa, Akira Tachibana, Takanosuke Yoshikawa, Takuto Shimizu, Nobumichi Tanaka, Keisuke Kiba, Mitsuru Tomizawa, Satoshi Anai, Kiyohide Fujimoto, Shinichiro Mizobuchi
Publikováno v:
Clinical genitourinary cancer. 20(2)
Micro-abstract The optimal first-line chemotherapy regimen and dose adjustment for cisplatin-unfit patients with advanced urothelial carcinoma remains unclear in the era of immune checkpoint inhibitors. We investigated the association between respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d8056f5987d64eda4b59b6fcf656fa
https://pubmed.ncbi.nlm.nih.gov/34916166
https://pubmed.ncbi.nlm.nih.gov/34916166
Autor:
Takuya Owari, Makito Miyake, Yasushi Nakai, Isao Asakawa, Fumisato Maesaka, Nobumichi Tanaka, Satoshi Anai, Tomomi Fuji, Masatoshi Hasegawa, Kaori Yamaki, Kiyohide Fujimoto, Kazumasa Torimoto
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationReferences. 29(2)
OBJECTIVE Higher quality of postimplant dosimetric evaluation is associated with higher biochemical recurrence-free survival rates after low-dose-rate brachytherapy for localized prostate cancer. Postimplant prostate D90 is a key dosimetric parameter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::219c642fc144317dfb7ad8137ab95e6d
https://pubmed.ncbi.nlm.nih.gov/34763369
https://pubmed.ncbi.nlm.nih.gov/34763369